Iradimed Corp. (IRMD) Reports In-Line Q3 EPS
Get Alerts IRMD Hot Sheet
Join SI Premium – FREE
Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.55, in-line with the analyst estimate of $0.55. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $23.47 million.
For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Starts H2O America (HTO) at Outperform
- HSBC Upgrades Delhivery Ltd (DELHIVER:IN) to Buy
- Reliance Industries (RELIANCE:IN) PT Lowered to INR1,840 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share